Issues with care in the elderly patient presenting with acute ischemia

Current Heart Failure Reports

Volumn 3, Issue 2, 2006, Pages 51-56

  Gharacholou, S Michael ^b   Alexander, Karen P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBIN; ANTITHROMBOCYTIC AGENT; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN;

ACUTE CORONARY SYNDROME; AGED; AGING; BLOOD CLOTTING; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; CORONARY STENT; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; PATHOPHYSIOLOGY; PATIENT CARE; PRACTICE GUIDELINE; REVIEW; TREATMENT OUTCOME;

AGED; CARDIOVASCULAR AGENTS; GERIATRIC ASSESSMENT; HUMANS; MYOCARDIAL ISCHEMIA;

EID: 33750372014     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-006-0002-1     Document Type: Review

References (50)

1. Kochanek KD, Smith BL: Deaths: Preliminary Data for 2002. National Vital Statistics Reports, vol 52, no 13. Hyattsville, MD: National Center for Health Statistics; 2004.
2. Gurwitz JH, Goldberg RJ, Chen Z, et al.: Recent trends in hospital mortality of acute myocardial infarction-the Worcester Heart Attack Study: have improvements been realized for all age groups? Arch Intern Med 1994, 154:2202-2208.
3. Goldberg RJ, Yarzebski J, Lessard D, Gore JM: A two-decades (1975-1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol 1999, 33:1533-1539.
4. Lee PY, Alexander KP, Hammill BG, et al.: Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001, 286:708-713.
5. Brieger D, Eagle KA, Goodman SG, et al.: Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events. Chest 2004, 126:461-469. Report from GRACE of characteristics and outcomes of patients who present with atypical symptoms defined as lack of chest pain. Particularly important for its implications to elderly populations with ischemia.
6. Kannel WB, Abbott RD: Incidence and prognosis of unrecognized myocardial infarction: an update on the Framingham study. N Engl J Med 1984, 311:1144-1147.
7. Goldberg RJ, Yarzebski J, Lessard D, Gore JM: Decade-long trends and factors associated with time to hospital presentation in patients with acute myocardial infarction: the Worcester Heart Attack Study. Arch Intern Med 2000, 160:3217-3223.
8. Goff DC, Feldman HA, McGovern PG, et al.: Prehospital delay in patients hospitalized with heart attack symptoms in the United States: the REACT trial. Am Heart J 1999, 138:1046-1057.
9. Grossman SA, Brown DF, Chang Y, et al.: Predictors of delay in presentation to the ED in patients with suspected acute coronary syndromes. Am J Emerg Med 2003, 21:425-428.
10. Fuster V, Badimon L, Badimon JJ, Chesebro JH: The pathogenesis of coronary artery disease and the acute coronary syndrome. N Engl J Med 1992, 326:242-250, 310-318.
11. Braunwald E: Unstable angina: an etiologic approach to management. Circulation 1998, 98:2219-2222.
12. Alexander KP, Biswas MS: Heart failure and the elderly: disease diversity, data, and delivery of care. Am Heart J 2003, 146:194-196.
13. Aurigemma GP, Gaasch WH: Diastolic heart failure. N Engl J Med 2004, 351:1097-1105.
14. Yusuf S, Pfeffer MA, Swedberg K, et al.: Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003, 362:777-781.
15. Boutouyrie P, Tropeano AI, Asmar R, et al.: Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients. Hypertension 2002, 39:10-15.
16. Lakatta EG, Levy D: Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part II: the aging heart in health: links to heart disease. Circulation 2003, 107:346-354.
17. Blackwell KA, Sorenson JP, Richardson DM, et al.: Mechanisms of aging-induced impairment of endothelium-dependent relaxation: role of tetrahydrobiopterin. Am J Physiol Heart Circ Physiol 2004, 287:H2448-H2453.
18. Mari D, Mannucci PM, Coppola B, et al.: Hypercoagulability in centenarians: the paradox of successful aging. Blood 1995,85:3144-3149.
19. Braunwald E, Antman EM, Beasley JW, et al.: ACC/AHA guideline update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Unstable Angina); 2002. Available at http://www.acc.org/clinical/ guidelines/unstable/unstable.pdf
20. Antman EM, Anbe DT, Armstrong PW, et al.: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines. J Am Coll Cardiol 2004, 44:671-719.
21. Fried LP, Tangen CM, Walston J, et al.: Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56:M146-156.
22. Walston J, McBurnie MA, Newman A, et al.: Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 2002, 162:2333-2341. Report of findings in the Cardiovascular Health Study linking syndrome of frailty to inflammatory and coagulation activation.
23. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet 2002, 360:7-22.
24. Montamat SC, Cusack BJ, Vestal RE: Management of drug therapy in the elderly. N Engl J Med 1989, 321:303-309.
25. Herzog CA, Ma JZ, Collins AJ: Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998, 339:799-805.
26. Sorensen CR, Brendorp B, Rask-Madsen C, et al.: The prognostic importance of creatinine clearance after acute myocardial infarction. Eur Heart J 2002, 23:948-952.
27. Al Suwaidi J, Reddan DN, Williams SK, et al.: Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002, 106:974-980.
28. Beattie JN, Soman SS, Sandberg KR, et al.: Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 2001, 37:1191-1200.
29. Santopinto JJ, Fox KA, Goldberg RJ, et al.: Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart 2003, 89:1003-1008.
30. Shlipak MG, Heidenreich PA, Noguchi H, et al.: Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002, 137:555-562.
31. Pinsky JL, Jette AM, Branch LG, Kannel WB: The Framingham disability study: relationship of various coronary heart disease manifestations to disability in older persons living in the community. Am J Public Health 1990, 80:1363-1367.
32. Ferrucci L, Guralnik JM, Studenski S, et al.: Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc 2004, 52:625-634.
33. Ades PA: Introduction-the elderly in cardiac rehabilitation. Am J Geriatr Cardiol 1999, 8:61-62.
34. Gurwitz JH, Col NF, Avorn J: The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992, 268:1417-1422.
35. Bowling A: Ageism in cardiology. BMJ 1999, 319:1353-1355.
36. Yusuf S, Furberg CD: Are we biased in our approach to treating elderly patients with heart disease? Am J Cardiol 1991, 68:954-956.
37. Alter DA, Manuel DG, Gunraj N, et al.: Age, risk-benefit trade-offs, and the projected effects of evidence based therapies. Am J Med 2004, 116:540-545. An assessment of the extrapolation of trial data to populations not studied, specifically the elderly, which emphasized that their increased burden of disease makes the elderly likely to achieve similar or greater benefit from therapy despite lack of representation in trials.
38. Ohman EM, Roe MT, Smith SC, et al.: Care of non-ST-segment elevation patients: insights from the CRUSADE national quality improvement initiative. Am Heart J 2004, 148:S34-S39.
39. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group: Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994, 343:311-322.
40. Eagle KA, Goodman SG, Avezum A, et al.: Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002, 359:373-377.
41. Barron HV, Bowlby LJ, Breen T, et al.: Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. Circulation 1998, 97:1150-1156.
42. White HD: Thrombolytic therapy in the elderly. Lancet 2000, 356:2028-2030.
43. Gore JM, Granger CB, Simoons ML, et al.: Stroke after thrombolysis: mortality and functional outcomes in the GUSTO-I trial. Circulation 1995, 92:2811-2818.
44. Cohen M, Demers C, Gurfinkel EP, et al.: A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med 1997, 337:447-452.
45. Antithrombotic Trialists' Collaboration: Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002, 324:71-86.
46. Krumholz HM, Radford MJ, Ellerbeck EF, et al.: Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries. Circulation 1995, 92:2841-2847.
47. Boersma E, Harrington RA, Moliterno DJ, et al.: Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomized clinical trials. Lancet 2002, 359:189-198.
48. Hasdai D, Holmes DR Jr, Criger DA, et al.: Age and outcome after acute coronary syndromes without persistent ST-segment elevation. Am Heart J 2000, 139:858-866.
49. Peterson ED, Pollack CV, Roe MT, et al.: Early use of glycoprotein IIb/IIIa inhibitors in non-ST segment elevation myocardial infarction. J Am Coll Cardiol 2003, 42:45-53.
50. Bach RG, Cannon CP, Weintraub WS, et al.: The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med 2004, 141:186-195. An analysis of benefit and risk of invasive or conservative management strategy in the elderly (age 65 years) in the TACTICS-TIMI-18 study, which demonstrates routine early invasive therapy improves ischemic outcomes with an associated risk of bleeding.